Home Clinical Psychology & Psychotherapy Propranolol as a Treatment for Anxiety

Propranolol as a Treatment for Anxiety

Reading Time: 4 minutes

Propranolol, a drug introduced in the 1960s, is primarily known as a beta-blocker used to treat cardiovascular conditions such as hypertension and angina. But over time, it has also been identified as an effective treatment for various anxiety disorders. Anxiety, a complex psychological condition, manifests through a combination of psychological and physical symptoms, often in a cyclical pattern that exacerbates the individual’s distress.

Propranolol’s effectiveness in managing anxiety is attributed to its ability to mitigate physical symptoms such as rapid heartbeat, sweating, and trembling, which are common in anxious states. By alleviating these physical manifestations, the drug can help break the cycle of anxiety where physical symptoms intensify psychological distress, leading to a more manageable experience for the patient.

Interestingly, this medication does not directly impact the psychological aspects of anxiety, such as worry or fear, but its role in controlling physical symptoms can indirectly contribute to a calmer mental state. Research has shown that patients using propranolol for anxiety often report a significant reduction in their anxiety levels, particularly in situations like public speaking or performance anxiety. It’s important, however, to note that propranolol is not a cure for anxiety disorders and should be considered as part of a comprehensive treatment plan that may include therapy and other medications.

The multifaceted nature of anxiety symptoms

Anxiety symptoms are generally classified into two categories: psychological and physical. Psychological symptoms include thought patterns characterised by excessive fear and worry, disrupting daily life. In contrast, physical symptoms arise from the body’s fight-or-flight response, leading to physiological changes like increased blood pressure, muscle tension, difficulty breathing, rapid heartbeat, and chest pain.

These physical symptoms are often interconnected with the psychological aspects of anxiety, creating a feedback loop that can exacerbate the overall anxiety experience. For instance, the physical sensation of a rapid heartbeat can heighten a person’s sense of fear, further intensifying their psychological anxiety symptoms. This interplay highlights the importance of addressing both the mental and physical aspects of the treatment of anxiety disorders. Cognitive behavioural therapy (CBT), for example, is a common psychological treatment that helps individuals reframe negative thought patterns to reduce psychological symptoms. Simultaneously, relaxation techniques such as deep breathing, meditation, and yoga can be effective in managing the physical symptoms by promoting a state of calm and reducing the body’s stress response.

Propranolol’s role in anxiety management

Propranolol’s effectiveness in anxiety treatment is largely attributed to its role in regulating the body’s stress response. This response is governed by epinephrine (adrenaline) and norepinephrine, which are released by the sympathetic nervous system. Propranolol works by blocking the effects of these chemicals, thereby reducing physical symptoms of anxiety such as rapid heartbeat and trembling.

By inhibiting the action of epinephrine and norepinephrine, propranolol effectively dampens the body’s fight-or-flight response, which is typically overactive in individuals with anxiety disorders. This leads to a decrease in heart rate and blood pressure, making the physical sensations of anxiety less intense and more manageable. As a result, patients often find that their overall anxiety levels are reduced as they are less overwhelmed by physical symptoms.

This can also have a positive psychological effect, as the reduction in physical symptoms can help break the cycle of anxiety where physical discomfort contributes to increased psychological distress. However, it’s important to note that while propranolol can be highly effective in managing physical symptoms of anxiety, it should be used as part of a broader treatment strategy that includes psychological therapies and lifestyle changes to address the root causes of anxiety.

Research and application

Recent studies have expanded the scope of propranolol’s use in treating anxiety. For instance, a 2023 study highlighted its potential benefits in improving social communication and reducing anxiety in individuals with autism spectrum disorder. This indicates the versatility of propranolol in managing anxiety across different conditions and age groups.

The study’s findings suggest that propranolol may help alleviate some of the social and communicative challenges faced by individuals with autism by reducing anxiety levels, which can be a significant barrier to social interaction. Moreover, its use in younger populations marks a significant shift, as most anxiety treatments have traditionally focused on adults. This expansion of propranolol’s application demonstrates its potential as a more universal treatment option, adaptable to various demographic groups.

The research underscores the importance of personalised medicine, as the effectiveness of propranolol can vary based on individual physiological and psychological profiles. These developments open new avenues for exploring how existing medications can be repurposed to treat a broader range of psychological conditions, potentially leading to more effective and tailored treatment strategies.

Dosage and effectiveness

The onset and duration of propranolol’s effects vary based on factors like age, liver and kidney function, and the type of formulation (regular-release tablets or extended-release capsules). Typically, it begins to work about 30 minutes after ingestion, providing relief for several hours. Its ability to alleviate anxiety depends on the individual’s specific circumstances, making it crucial for healthcare providers to tailor the dosage and frequency to each patient’s needs.

The absorption and metabolism of propranolol can differ significantly among individuals, influencing how quickly and effectively it works. For example, older adults or those with impaired liver or kidney function may process the drug more slowly, leading to prolonged effects or an increased risk of side effects. Conversely, in some individuals, the drug might be metabolised more quickly, necessitating more frequent dosing to maintain its therapeutic effect.

The choice between regular-release and extended-release formulations also plays a critical role in managing the timing and intensity of propranolol’s effects. Extended-release capsules provide a more sustained effect, ideal for long-term management of symptoms, whereas regular-release tablets may be more suitable for acute situations requiring rapid relief. This variability underscores the need for careful monitoring and adjustment of propranolol therapy to achieve optimal benefits while minimising potential risks.


Propranolol has proven to be a valuable tool in the management of anxiety disorders, offering relief from both psychological and physical symptoms. Its role in treating various forms of anxiety, including PTSD and performance anxiety, highlights its significance in contemporary mental health treatment.

Its use in PTSD (posttraumatic stress disorder) is particularly noteworthy, as propranolol can help diminish the physiological arousal associated with traumatic memories, thus aiding in the therapeutic process. In cases of performance anxiety, such as public speaking or musical performances, propranolol’s ability to control physical symptoms like tremors and palpitations allows individuals to focus more on the task at hand, reducing overall anxiety levels.

The drug’s non-addictive nature and relatively mild side-effect profile compared to other anxiety medications make it an appealing option for many. This versatility demonstrates propranolol’s potential as a first-line treatment in certain anxiety-related conditions. However, its efficacy as a standalone treatment versus as part of a combined therapy approach, including psychological interventions, remains a topic of ongoing research and clinical debate.

Alicia Watkins, PhD is a clinical psychologist from New Jersey.

© Copyright 2014–2034 Psychreg Ltd